Zai Lab Ltd financial data

Symbol
ZLAB on Nasdaq
Industry
Pharmaceutical Preparations
Location
4560 Jinke Road, Bldg. 1, 4 F, Pudong, Shanghai, China
State of incorporation
Cayman Islands
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 474 % -40.7%
Quick Ratio 21.9 % -10.7%
Debt-to-equity 29 % +67%
Return On Equity -38 % +1.35%
Return On Assets -29.4 % +10.2%
Operating Margin -137 % +26.9%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 981M shares +1.33%
Entity Public Float 2.7B USD -15.6%
Common Stock, Value, Issued 6K USD 0%
Weighted Average Number of Shares Outstanding, Basic 976M shares +1.15%
Weighted Average Number of Shares Outstanding, Diluted 976M shares +1.15%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 101M USD +45.9%
Revenue from Contract with Customer, Excluding Assessed Tax 322M USD +28.6%
Cost of Revenue 108M USD +35.6%
Research and Development Expense 257M USD -11.9%
Operating Income (Loss) -354M USD +8.05%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -80.3M USD +33.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -298M USD +24.1%
Earnings Per Share, Basic -0.3 USD/shares +26.8%
Earnings Per Share, Diluted -0.3 USD/shares +26.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 630M USD -26.7%
Accounts Receivable, after Allowance for Credit Loss, Current 69.6M USD +47.3%
Inventory, Net 41.8M USD +15.1%
Assets, Current 870M USD -14.5%
Property, Plant and Equipment, Net 50.6M USD -10.3%
Operating Lease, Right-of-Use Asset 13.1M USD -29.3%
Intangible Assets, Net (Excluding Goodwill) 44.1M USD +2507%
Assets 987M USD -10.8%
Accounts Payable, Current 127M USD +90%
Employee-related Liabilities, Current 22.4M USD +18.2%
Liabilities, Current 252M USD +88.8%
Operating Lease, Liability, Noncurrent 5.8M USD -50.6%
Other Liabilities, Noncurrent 325K USD 0%
Liabilities 283M USD +62.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 42.8M USD -18%
Retained Earnings (Accumulated Deficit) -2.33B USD -14.7%
Stockholders' Equity Attributable to Parent 704M USD -24.5%
Liabilities and Equity 987M USD -10.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -90.1M USD -30%
Net Cash Provided by (Used in) Financing Activities 47.5M USD
Net Cash Provided by (Used in) Investing Activities 3.29M USD
Common Stock, Shares Authorized 5B shares 0%
Common Stock, Shares, Issued 986M shares +1.33%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -39.4M USD +69.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 45K USD
Deferred Tax Assets, Valuation Allowance 358M USD +26%
Operating Lease, Liability 15.2M USD -25.7%
Depreciation 8.5M USD +1.19%
Payments to Acquire Property, Plant, and Equipment 974K USD -72.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -308M USD +10.9%
Lessee, Operating Lease, Liability, to be Paid 15.6M USD -26.6%
Property, Plant and Equipment, Gross 84.5M USD +3.02%
Operating Lease, Liability, Current 7.58M USD +3.86%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.14M USD -16.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.44M USD -1.55%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 460K USD -48%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.81M USD -60.5%
Deferred Tax Assets, Operating Loss Carryforwards 295M USD +22.3%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 822K USD -52.6%
Depreciation, Depletion and Amortization 3.01M USD +13.4%
Deferred Tax Assets, Net of Valuation Allowance 2.83M USD -24.4%
Share-based Payment Arrangement, Expense 79.1M USD +10.1%
Interest Expense 113K USD